CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 32 enrolled
Drug / intervention
All participants (Aviane) +2 moredrug
Likely dose
All participants (Aviane) 20 mcgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01170390
NCT01170390Phase 4Completed
CompareCT.gov

Improving Contraceptive Effectiveness in Obese Women

Oregon Health and Science University·interventional·Posted Jul 27, 2010·Updated Dec 31, 2015

In Brief

A Phase 4 clinical trial evaluating All participants (Aviane), Portia, and 1 other intervention for Body Weight and Contraceptive Usage. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The main hypothesis for this study is that increased Body Mass Index (BMI) alters oral contraceptive metabolism in a manner which results in decreased effectiveness in obese women.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBody Weight, Contraceptive Usage
CountriesUnited States
CollaboratorsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJul 27, 2010
Enrollment StartSep 1, 2009
Primary CompletionMar 1, 2011
Study CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 15.9 years ago

Interventions

All participants (Aviane)drug

20 mcg EE/0.1 mg LNG cyclically

Portiadrug

30 mcg EE/0.15 mg LNG cyclically

Avianedrug

20 mcg EE/0.1 mg LNG continuously dosed